Poder, A., Simurka, P., Li, P., Roy-Ghanta, S., & Vaughn, D. (2014). An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age. Vaccine, 32(9), 1121. https://doi.org/10.1016/j.vaccine.2013.11.031
Chicago Style (17th ed.) CitationPoder, Airi, Pavol Simurka, Ping Li, Sumita Roy-Ghanta, and David Vaughn. "An Observer-blind, Randomized, Multi-center Trial Assessing Long-term Safety and Immunogenicity of AS03-adjuvanted or Unadjuvanted H1N1/2009 Influenza Vaccines in Children 10–17 Years of Age." Vaccine 32, no. 9 (2014): 1121. https://doi.org/10.1016/j.vaccine.2013.11.031.
MLA (9th ed.) CitationPoder, Airi, et al. "An Observer-blind, Randomized, Multi-center Trial Assessing Long-term Safety and Immunogenicity of AS03-adjuvanted or Unadjuvanted H1N1/2009 Influenza Vaccines in Children 10–17 Years of Age." Vaccine, vol. 32, no. 9, 2014, p. 1121, https://doi.org/10.1016/j.vaccine.2013.11.031.